BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Whereas the parental CML cell lines were dependent on the BCR–ABL pathway, by contrast, the CML iPSCs were independent of this BCR–ABL signaling and showed resistance to imatinib.